Currently, Long-Acting GLP-1 Agonists Occupy the Largest Share of the GLP-1 Market Based on the type of GLP-1 agonists drugs, the market is segmented into short-acting GLP-1 agonist and long-acting GLP-1 agonist
[DOI] [PMC free article] [PubMed] [Google Scholar] 178
That matters on a GLP-1 because the medication itself, combined with rapid weight loss, can put stress on your body
Eligibility typically requires a specific BMI range, may exclude certain medical conditions, and requires you to be near a participating research site
The good thing is psilocin is available in lozenges, as are substances like LSD and ketamine, so this theory can be put to the test in the future to bypass the issue of digestion for those who take GLP-1s or similar medication and would prefer not to taper off of them
Ilene Ruhoy, and listen to Episode 132 of the Bendy Bodies Podcast